In this Perspective, authors argue for a more robust and comprehensive postmarket surveillance program of psychedelic-assisted psychotherapy to better ensure safe, appropriate and equitable care for patients.
- Joshua C. Black
- Andrew A. Monte
- Richard C. Dart